EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

Market Cap	30.71B
Revenue (ttm)	8.03B
Net Income (ttm)	1.94B
Shares Out	685.26M
EPS (ttm)	2.83
PE Ratio	15.83
Forward PE	n/a
Dividend	1.75 (3.95%)
Ex-Dividend Date	May 14, 2025

Volume	713,855
Average Volume	7,484,496
Open	45.06
Previous Close	44.82
Day's Range	45.00 - 45.30
52-Week Range	37.20 - 64.80
Beta	0.03
RSI	49.53
Earnings Date	Aug 5, 2025

About IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment produces and sells human health and veterinary medicines, as well as engages in pharmaceutical sales and marketing. Its Real Estate Development segment develops real estate properties; engages in leasing activities for serum facilities; and provides consulting services on land development and project management. The company was incorporate...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,088
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2024, IST:ECILC's revenue was 8.77 billion, a decrease of -6.28% compared to the previous year's 9.36 billion. Earnings were 1.02 billion, a decrease of -74.12%.